Klinische Bedeutung von p53 Tumor-Suppressor-Gen Mutationen beim Adenocarcinom im Barrett-Osophagus.

P. M. Schneider; A. H. Hölscher; S. Wegerer; U. König; K. Becker; J. R. Siewert

Klinische Bedeutung von p53 Tumor-Suppressor-Gen Mutationen beim Adenocarcinom im Barrett-Osophagus.

Translated title of the contribution: Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus

P. M. Schneider, A. H. Hölscher, S. Wegerer, U. König, K. Becker, J. R. Siewert

Default

Technical University of Munich

Research output: Contribution to journal › Article › peer-review

Abstract

p53 mutations are involved in the pathogenesis of adenocarcinomas in Barrett's esophagus. Our study included patients with histopathologically classified Barrett's cancer and shows that p53 mutations are clinically important for curatively resected (R0) Barrett's cancer. It appears that the p53 mutation status is a promising parameter for the definition of risk groups after potentially curative resections.

Translated title of the contribution	Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus
Original language	German
Pages (from-to)	495-499
Number of pages	5
Journal	Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress
Volume	115
Issue number	Suppl I
State	Published - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{093cf0d41ca345cd825b7be39b658366,

title = "Klinische Bedeutung von p53 Tumor-Suppressor-Gen Mutationen beim Adenocarcinom im Barrett-Osophagus.",

abstract = "p53 mutations are involved in the pathogenesis of adenocarcinomas in Barrett's esophagus. Our study included patients with histopathologically classified Barrett's cancer and shows that p53 mutations are clinically important for curatively resected (R0) Barrett's cancer. It appears that the p53 mutation status is a promising parameter for the definition of risk groups after potentially curative resections.",

author = "Schneider, {P. M.} and H{\"o}lscher, {A. H.} and S. Wegerer and U. K{\"o}nig and K. Becker and Siewert, {J. R.}",

year = "1998",

language = "Deutsch",

volume = "115",

pages = "495--499",

journal = "Langenbecks Archiv f{\"u}r Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft f{\"u}r Chirurgie. Kongress",

issn = "0942-2854",

publisher = "Springer Verlag",

number = "Suppl I",

}

Klinische Bedeutung von p53 Tumor-Suppressor-Gen Mutationen beim Adenocarcinom im Barrett-Osophagus. / Schneider, P. M.; Hölscher, A. H.; Wegerer, S. et al.
In: Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress, Vol. 115, No. Suppl I, 1998, p. 495-499.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Klinische Bedeutung von p53 Tumor-Suppressor-Gen Mutationen beim Adenocarcinom im Barrett-Osophagus.

AU - Schneider, P. M.

AU - Hölscher, A. H.

AU - Wegerer, S.

AU - König, U.

AU - Becker, K.

AU - Siewert, J. R.

PY - 1998

Y1 - 1998

N2 - p53 mutations are involved in the pathogenesis of adenocarcinomas in Barrett's esophagus. Our study included patients with histopathologically classified Barrett's cancer and shows that p53 mutations are clinically important for curatively resected (R0) Barrett's cancer. It appears that the p53 mutation status is a promising parameter for the definition of risk groups after potentially curative resections.

AB - p53 mutations are involved in the pathogenesis of adenocarcinomas in Barrett's esophagus. Our study included patients with histopathologically classified Barrett's cancer and shows that p53 mutations are clinically important for curatively resected (R0) Barrett's cancer. It appears that the p53 mutation status is a promising parameter for the definition of risk groups after potentially curative resections.

UR - http://www.scopus.com/inward/record.url?scp=0142248487&partnerID=8YFLogxK

M3 - Artikel

C2 - 14518305

AN - SCOPUS:0142248487

SN - 0942-2854

VL - 115

SP - 495

EP - 499

JO - Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress

JF - Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress

IS - Suppl I

ER -

Klinische Bedeutung von p53 Tumor-Suppressor-Gen Mutationen beim Adenocarcinom im Barrett-Osophagus.

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this